Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis  

作　　者：Daniel B.Spielman Jonathan Overdevest David A.Gudis 

机构地区：[1]Departm ent of Otolaryngology-Head and Neck Surgery,Columbia University Medical Center,New York,NY,10032,USA

出　　处：《World Journal of Otorhinolaryngology-Head and Neck Surgery》2020年第4期207-213,共7页世界耳鼻咽喉头颈外科杂志（英文）

摘　　要：Patients with aspirin exacerbated respiratory disease(AERD)experience a severe and recalcitrant form of chronic rhinosinusitis with nasal polyposis(CRSwNP)and asthma,which are exacerbated by aspirin/NSAID ingestion.As compared with aspirin-tolerant CRSwNP,patients with AERD experience more severe olfactory dysfunction,which is one of the key contributors to the observed decrease in quality of life(QOL)in this disease.The objective of this paper is to review the published olfactory outcomes observed with various treatment modalities.

关 键 词：Aspirin exacerbated respiratory disease AERD Samter’s Triad OLFACTION HYPOSMIA Endoscopic sinus surgery Aspirin desensitization NSAID 

分 类 号：R765.41[医药卫生—耳鼻咽喉科]